Credit Suisse Ag Amicus Therapeutics, Inc. Put Options Transaction History

Credit Suisse Ag

3 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q1 2018 May 15, 2018	SELL	$13.76 - $17.12 $14.4 Million - $18 Million	-1,049,700 Reduced 79.06%	278,100 $4.18 Million
Q4 2017 Feb 14, 2018	BUY	$12.51 - $16.24 $4.41 Million - $5.73 Million	352,800 Added 36.18%	1,327,800 $19.1 Million
Q3 2017 Nov 14, 2017	BUY	$11.74 - $15.78 $11.4 Million - $15.4 Million	975,000	975,000 $14.7 Million

317

315M

530K

569K

Ticker FOLD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 280,497,984
Market Cap $2.74B
Description
Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant bas...

Get notified when there are updates to the investment portfolio of Credit Suisse Ag, based on Form 13F filings with the SEC.

Stay updated on Credit Suisse Ag with notifications on news.